Exchange: NASDAQ·Updated 04:10 PM EDT
LGND logo

LGNDLigand Pharmaceuticals, Inc. - Ordinary Shares - Class B

$296.29
$8.28
(2.88%)
Today
Closed $296.29
$0.00
(0.00%)
After Hours
EarningsAug 6
Mkt Cap$5.77B
Vol270,975.00
Upcoming Earnings: Q2 '26

Reports: Aug 06Pre-Market

Estimated EPS

$1.84

Estimated Rev

$61.4M

$LGND Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.67 up 69.68% YoY • Reported revenue of $51.72M up 14.09% YoY • Ligand reaffirms its 2026 full-year financial guidance, expecting adjusted earnings per diluted share of $8.50 to $9.50 and total revenue of $270M to $310M, reflecting partial-year XOMA contribution.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '26
$1.84
--
--
N/A
Q1 '26
$1.82
$1.63
-10.23%
MISSED
Q4 '25
$1.50
$2.02
34.92%
BEAT
Q3 '25
$1.93
$3.09
60.24%
BEAT
Q2 '25
$1.42
$1.60
12.56%
BEAT

Advertisement|Remove ads.